The RET proto-oncogene, encoding a receptor tyrosine kinase, is the susceptibility gene for Hirschsprung disease (HSCR), a congenital absence of enteric ganglia, and for multiple endocrine neoplasia type 2 (MEN 2), an inherited cancer syndrome and neurocristopathy. MEN 2 are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and parathroid hyperplaisa. Four related ligands are needed to bind to four related coreceptors before binding to RET. High penetrance gain of function mutations cause MEN 2 and loss of function mutations cause a subset of HSCR (30-50 percent of familial and 3 percent of isolated cases). Recently, the PIs have found 2 polymorphisms, A45A and L769L within the RET gene that are associated with HSCR in small sample. In contrast S836S are over-represented in individuals with sporadic MTC, particularly those with M918T polymorphism in their tumors. Based on these preliminary genetic findings, the PIs hypothesize that common low penetrance alleles within RET can act as low level susceptibility alleles predisposing to HSCR. Further, they hypothesize that the variants associated with HSCR will be underrepresented in sporadic MTC cases and vice versa. To test these hypotheses, the PIs will accrue a large population-based series of HSCR cases (n=250) and sporadic MTC (n=200) to determine the frequency of polymorphic variants in RET and to determine their haplotypes. Race-matched, region-matched normal controls will be accrued with cases: control ratio of 1:3. These data will be analyzed using the standard case-control matched association analysis, the transmission-disequilibrium test, and the haplotype-based linkage disequilibrium analysis. These methods have been used on a pilot series of 64 HSCR and unaffected parents and found evidence for a novel low penetrance locus with 15kb upstream and including codon 45 which could predispose to the majority of isolated HSCR. The PIs plan to extend their investigations to isolate this new locus and to directly test this locus in the extended series of HSCR. Further, the genes encoding the ligands and coreceptors of RET are equally good candidates for low penetrance susceptibility genes. Genotyping and haplotyping of these genes and similar tests of association will be performed in HSCR and MTC. Finally variants found to be associated with disease status will be tested functionally at the transcript, protein and cell biological level.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD039058-04
Application #
6749593
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Henken, Deborah B
Project Start
2001-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2006-06-30
Support Year
4
Fiscal Year
2004
Total Cost
$315,870
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Peczkowska, Mariola; Erlic, Zoran; Hoffmann, Michael M et al. (2008) Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1. J Clin Endocrinol Metab 93:4818-25
Peczkowska, Mariola; Cascon, Alberto; Prejbisz, Aleksander et al. (2008) Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nat Clin Pract Endocrinol Metab 4:111-5
Neumann, Hartmut P H; Vortmeyer, Alexander; Schmidt, Dieter et al. (2007) Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med 357:1311-5
Bausch, Birke; Borozdin, Wiktor; Mautner, Victor F et al. (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 92:2784-92
Bausch, Birke; Koschker, Ann-Cathrin; Fassnacht, Martin et al. (2006) Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab 91:3478-81
Fernandez, Raquel M; Pecina, Ana; Antinolo, Guillermo et al. (2006) Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma. Thyroid 16:411-7
Schiavi, Francesca; Boedeker, Carsten C; Bausch, Birke et al. (2005) Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057-63
McWhinney, Sarah R; Pilarski, Robert T; Forrester, Shawnia R et al. (2004) Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 89:5694-9
Neumann, Hartmut P H; Pawlu, Christian; Peczkowska, Mariola et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-51
Vanharanta, Sakari; Buchta, Mary; McWhinney, Sarah R et al. (2004) Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74:153-9

Showing the most recent 10 out of 23 publications